The impact of a secondary, rare, non-pathogenic PKD1 variant on disease progression in autosomal dominant polycystic kidney disease.
Elhassan EAE, Collins KE, Heneghan S, Gilbert E, Yang H, Senum SR, Schauer RS, Elbarougy DE, Madden SF, Murray SL, Sadeghi-Alavijeh O, Carmichael J, Gale D, Osman SM, Kennedy C, Griffin MD, Casserly L, Moloney B, O'Hara P, Mallawaarachchi A, Ciurli F; Genomics England Consortium; Graziano C, Wolff CA, Schönauer R, LaManna G, Durand A, Limou S, Halbritter J, Capelli I, McCann E, Harris PC, Cavalleri GL, Benson KA, Conlon PJ.
Elhassan EAE, et al.
J Nephrol. 2025 Jan 30. doi: 10.1007/s40620-025-02211-x. Online ahead of print.
J Nephrol. 2025.
PMID: 39883360